Janux Therapeutics is a biotechnology company dedicated to advancing the field of cancer treatment through the development of unique protein-based therapeutics. The company utilizes its proprietary technology platform to create innovative, targeted therapies that aim to improve patient outcomes in oncology. Janux's mission revolves around transforming the treatment landscape for patients with cancer by ensuring that its therapeutics are designed to target tumor-specific antigens effectively. Core values at Janux emphasize collaboration, integrity, and a commitment to scientific excellence and quality. By fostering a culture that encourages innovative thinking and teamwork, Janux strives to attract talented individuals who are passionate about making a significant impact in the realm of cancer therapeutics. Employees at Janux play a vital role in bringing novel products from the laboratory to clinical trials, influencing the future of cancer care for patients worldwide.